Back to Results
First PageMeta Content
Occupational diseases / Mesothelioma / Eli Lilly and Company / Alkylating antineoplastic agents / Raja M. Flores / Pneumonectomy / Gemcitabine / Amifostine / Cisplatin / Medicine / Chemistry / Asbestos


Document Date: 2010-10-19 13:00:57

Open Document

File Size: 42,04 KB

Share Result on Facebook

City

Boston / /

Company

CBC / Institutional Review / /

Country

United States / /

/

Facility

Hospital International Mesothelioma Program / Dana-Farber Cancer Institute / Hospital Recruiting Boston / Hospital More Information International Mesothelioma Program Brigham / Hospital Dana-Farber Cancer Institute Information / /

MedicalCondition

concomitant systemic disorders / Trimethoprim Amifostine Cisplatin Sodium thiosulfate Trichloroethylene Gemcitabine Adenoma Neoplasms / disease / Antineoplastic Immunologic Factors Neoplasms / pulmonary function / thrombocytopenia / stop tumor / visible cancer / Mesothelioma / III malignant mesothelioma / malignant pleural mesothelioma / visable tumor / melanoma skin cancer / addictive disorder / Mesothelioma Antimetabolites Anti-Infective Agents Radiation-Protective Agents Antioxidants Neoplasms / /

MedicalTreatment

radiation therapy / combination chemotherapy / chemotherapy / surgery / /

Organization

Institutional Review Board Responsible Party / NCT00571298 Health Authority / Division of Thoracic Surgery / FDA / Dana-Farber Cancer Institute / /

Person

David J Sugarbaker / Women / Brigham / David Sugarbaker / David J. Sugarbaker / Tamara Tilleman / /

/

Position

Safety Study Official / Principal Investigator / Investigators Principal Investigator / /

Product

Cisplatin / Trimethoprim / Sodium Thiosulfate / Amifostine / /

ProvinceOrState

Massachusetts / /

Technology

pharmacokinetics / radiation / chemotherapy / /

URL

http /

SocialTag